[Published] 2025/3/25 [Last updated] 2025/3/25
Talking about the enhanced capabilities through collaboration, a fair number of global pharmaceutical and National Cancer Center Hospital expanded their comprehensive alliance partnership to bring innovative treatment to cancer patients by developing novel oncology therapies.
With an experience of more than 10 years in conducting the phase 1 trials including the First-in-Human phase 1 trials, our phase 1 program has been recognized as a key top recruiting center of the numerous number of the global phase 1 trials as well as the Center of Excellence for new drug development in Asia.
- AbbVie
- Abnova
- AstraZeneca
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Canon Medical Systems
- Daiichi Sankyo
- FUJITSU
- GSK
- Kyowa Hakko Kirin
- Merck
- Olympus
- ONO Pharmaceutical
- Pfizer
- Sanofi
- SHIMADZU
- Sysmex
- Takeda Oncology
- Thermo Fisher Scientific
